} Reuters Shares of CureVac, a German biotech company backed by Bill Gates, went as much as 18% into premarket trading on Thursday after the company said it was in talks with the European Commission to supply doses of its potential coronavirus vaccine. The potential contract with the European Commission …
Read More »
Reuters CureVac, a German-based biotechnology company, jumped $ 213.3 million and more than a third of its IPO price in its initial public offering on Friday. Shares of the company have continued to grow since its Friday IPO, gaining as much as 52% to $ 85 per share on Monday …
Read More »
Shares of CureVac were up about 25% on Monday after its CEO Franz-Werner Haas said in an interview with German financial news site Boerse Online over the weekend that he hopes the vaccine will be approved by regulators early next year. Haas added that even an “accelerated approval was possible”. …
Read More »
FILEFOTO: An employee of the German biopharmaceutical company CureVac, demonstrates research into a vaccine for coronavirus (COVID-19) at a laboratory in Tuebingen, Germany, March 12, 2020. REUTERS / Andreas Gebert FRANKFURT (Reuters) – German biotechnology company CureVac does not rule out a speedy approval process for its prospective vaccine against …
Read More »
German vaccine maker CureVac has lost some shine in the race for a COVID-19 vaccine after other mRNA-based applicants have caught the attention of regulators. Still, CureVac is reported to have caught a great partner to help build its game-changing RNA “printers” that could turn global interest in its favor. …
Read More »